Annual Meeting of the Japanese Society of Toxicology
The 43rd Annual Meeting of the Japanese Society of Toxicology
Session ID : S3-6
Conference information

Symposium 3
Points learnt from the first successful FDA (SEND) trial submission by a Japanese CRO - Approach and challenges
*Shinichi HORIKAWA
Author information
CONFERENCE PROCEEDINGS FREE ACCESS

Details
Abstract
[in Japanese]
Content from these authors
© 2016 The Japanese Society of Toxicology
Previous article Next article
feedback
Top